Conversion From Standard Phosphate Binder Therapy to Fosrenol® (Lanthanum Carbonate) in Chronic Kidney Disease Stage 5
Status:
Terminated
Trial end date:
2007-12-10
Target enrollment:
Participant gender:
Summary
The main aim of this research study is to see if giving Fosrenol®, a chewable tablet, to
patients on haemodialysis works as well as other treatments currently used to lower blood
phosphorus levels.